The enforcement of a patent right is only as meaningful as the remedies available when that right is infringed. A patent that cannot be effectively enforced whose violation attracts only nominal consequences or whose vindication requires years of inconclusive litigation provides little real protection to the inventor and little genuine deterrence to would-be infringers. Conversely, a system of remedies that is disproportionately harsh, that enables the grant of sweeping relief on the basis of inadequate scrutiny or that allows the patent system to be weaponised as an instrument of anti-competitive conduct causes harm that extends beyond the parties to individual disputes. The law of patent infringement remedies in India reflects the legislature’s attempt to calibrate this balance to provide patent holders with effective enforcement tools while ensuring that those tools are deployed in a manner proportionate to the infringement and consistent with the public interest. The principal remedies available in Indian patent infringement proceedings are the injunction both interlocutory and permanent damages or an account of profits and delivery up or destruction of infringing goods and materials. Each of these remedies is governed by a combination of specific statutory provisions in the Patents Act, 1970, the general principles of civil procedure under the Code of Civil Procedure, 1908 and the equitable jurisdiction of the courts developed through decades of judicial decision-making. Understanding these remedies in their full legal and practical dimensions is essential for patent holders seeking to enforce their rights, for defendants seeking to resist disproportionate relief and for practitioners advising on either side of patent infringement litigation in India.
The statutory foundation for remedies in patent infringement proceedings is Section 108 of the Patents Act, 1970, which provides that in a suit for infringement of a patent the court may grant an injunction subject to such terms, if any, as the court thinks fit and at the option of the plaintiff either damages or an account of profits, together with or without any order for the delivery up or destruction of the infringing goods, articles or documents in which the patent is embodied. Section 108 must be read in conjunction with Order XXXIX of the Code of Civil Procedure, which governs the grant of temporary injunctions and with the general equitable principles applicable to the exercise of the court’s discretion in fashioning remedies in civil proceedings. Together, these provisions and principles constitute the legal framework within which patent infringement remedies are sought, contested and granted in India.
The Injunction – The Primary Remedy
The injunction is the primary remedy in patent infringement litigation and the relief that is most frequently sought and most consequential in its commercial impact. An injunction restrains the defendant from continuing the infringing activities from making, using, selling, importing or otherwise exploiting the patented invention without authorisation and its grant effectively removes the infringing product or process from the market for as long as the injunction remains in force. The commercial consequences of an injunction against a pharmaceutical manufacturer, a technology company or a manufacturer of industrial goods can be enormous, affecting not only the defendant’s revenues but the supply of goods to consumers and the competitive dynamics of the relevant market.
Indian patent law recognises two forms of injunction: the interlocutory injunction, also called the interim injunction, which is granted at an early stage of the proceedings before the merits of the case have been fully determined; and the permanent injunction, which is granted upon the final determination of the infringement claim after a full trial. Each form of injunction is governed by different legal standards and serves different functions in the overall framework of patent enforcement.
The Interlocutory Injunction – The Three-Part Test
The interlocutory injunction is frequently the most commercially significant order in patent infringement proceedings, because the period between the filing of the suit and the final determination of the case on its merits which in India can extend to several years is precisely the period during which the infringing activities continue and during which the patent holder’s market position and commercial interests are most immediately threatened. A patent holder who obtains an interlocutory injunction effectively removes the infringing product from the market at an early stage, before the defendant has had the opportunity to fully establish its invalidity defences or to contest the infringement allegations on the merits. The stakes attached to the interlocutory injunction application are therefore high for both parties and the proceedings are typically hotly contested.
The legal standard for the grant of an interlocutory injunction in India is the three-part test established by the Supreme Court in Wander Ltd. v. Antox India P. Ltd., (1990) Supp SCC 727, which requires the applicant to demonstrate: first, that there is a prima facie case a serious question to be tried in its favour; second, that the balance of convenience favours the grant of the injunction that the harm to the applicant from refusing the injunction outweighs the harm to the defendant from granting it; and third, that the applicant would suffer irreparable harm if the injunction is not granted harm that cannot be adequately compensated by an award of damages at trial.
The application of this three-part test in patent cases has been the subject of extensive judicial attention and the courts have developed a nuanced understanding of how each element operates in the specific context of patent infringement. On the prima facie case element, the courts have consistently held that the applicant must demonstrate a reasonable prospect of establishing infringement at trial it is not sufficient to produce the patent certificate and assert that infringement has occurred. The court will examine the claims of the patent, consider the defendant’s product or process and assess whether there is a genuine question to be tried as to whether the claims read on the defendant’s activities. Where the defendant raises a credible invalidity defence by identifying relevant prior art, by arguing a Section 3 exclusion or by challenging the specification’s sufficiency the court must assess whether that defence is sufficiently strong to undermine the prima facie case, since a prima facie invalid patent cannot support the grant of an injunction.
In Bajaj Auto Ltd. v. TVS Motor Company Ltd., (2009) 9 SCC 797, the Supreme Court provided important guidance on the grant of interlocutory injunctions in patent cases, emphasising that courts should not grant injunctions in cases involving complex technical questions without adequate scrutiny of both the infringement allegations and the validity defences. The Court cautioned against the mechanical grant of injunctions on the basis of the patent certificate alone and held that the court must form a view on the strength of the patent and the seriousness of the invalidity challenge before exercising its discretion to grant interim relief.
The balance of convenience analysis in patent cases frequently engages public interest considerations that do not arise in most other forms of commercial litigation. In pharmaceutical patent cases particularly, the courts have repeatedly held that the public interest in access to affordable medicines is a factor of significant weight in the balance of convenience analysis and that a court exercising its discretion to grant an interim injunction must consider the impact of the injunction on patients who rely on the allegedly infringing generic product. In F. Hoffmann-La Roche Ltd. v. Cipla Ltd., the Delhi High Court’s refusal to grant an interim injunction against Cipla’s manufacture of generic Erlotinib was grounded in significant part on the balance of convenience analysis the Court holding that the harm to patients who would be denied access to an affordable cancer drug outweighed the harm to Roche from Cipla’s continued manufacture during the pendency of the proceedings. This decision has been profoundly influential in shaping the approach of Indian courts to interim injunctions in pharmaceutical patent cases and it established the principle that public interest in access to essential medicines is an independent consideration in the balance of convenience, not merely a background factor.
The irreparable harm element of the interlocutory injunction test is generally presumed in patent cases where infringement is established on a prima facie basis, on the theory that the continuation of infringing activity causes harm to the patent holder’s exclusive rights and market position that cannot be fully quantified and compensated by a subsequent award of damages. However, the courts have increasingly scrutinised whether the harm is truly irreparable particularly where the defendant has offered an undertaking to maintain accounts and to pay any damages that may ultimately be assessed at trial and have been more willing to refuse interim injunctions in cases where adequate security or undertakings have been offered.
The Permanent Injunction
A permanent injunction is the remedy granted upon the final determination of an infringement suit in the plaintiff’s favour. Unlike the interlocutory injunction, which is a temporary measure granted on the basis of a preliminary assessment of the merits, the permanent injunction is a final order made after a full examination of the infringement allegations and any defences, including invalidity defences. A permanent injunction restrains the defendant from continuing the infringing activities indefinitely for the remaining term of the patent and its grant in conjunction with a finding of infringement is, in the absence of special circumstances, the normal consequence of a successful infringement claim.
The courts retain a discretion in the grant of permanent injunctions and there are circumstances in which a court may decline to grant a permanent injunction even after finding infringement typically where the grant of an injunction would cause disproportionate harm to the public or to third parties, where the patent holder has delayed unreasonably in bringing proceedings or where the patent is near the end of its term and the infringement has substantially ceased. In cases where a permanent injunction is refused on account of public interest or other equitable considerations, the court may instead award damages that include an element compensating the patent holder for future use effectively compulsory licensing by judicial order, a remedy that has been used sparingly in India but is available in principle.
Damages – The Compensatory Remedy
Damages in patent infringement proceedings are a compensatory remedy they are designed to put the patent holder in the position it would have been in had the infringement not occurred, not to punish the infringer or to deprive it of benefits beyond those that directly correspond to the patent holder’s loss. Section 108 of the Patents Act provides that the plaintiff in an infringement suit may elect, at its option, either damages or an account of profits the two remedies being alternative rather than cumulative, so that the plaintiff must choose between them before the stage at which the quantum of the remedy is assessed.
The assessment of damages in patent infringement cases is one of the most complex exercises in commercial litigation, requiring the court to reconstruct a counterfactual world the world as it would have been had the infringement not occurred and to calculate the difference between that world and the world that actually existed. The two primary measures of patent infringement damages recognised in Indian law are lost profits the profits that the patent holder would have made on the sales that were diverted to the infringer and the reasonable royalty the royalty that the patent holder and the infringer would have agreed upon in a hypothetical arm’s length licence negotiation at the time the infringement began.
Lost profits damages require the patent holder to establish a causal link between the infringement and the lost sales to demonstrate that but for the infringement, the patent holder would have made the sales that the infringer in fact made. This requires evidence about the patent holder’s market position, its manufacturing and supply capacity, the competitive dynamics of the relevant market and the likely purchasing behaviour of the customers who bought from the infringer. In markets where the patent holder and the infringer are direct competitors selling equivalent products, the lost profits calculation is conceptually straightforward even if evidentially demanding. In markets where the patent holder does not itself sell the patented product as is the case with non-practising entities or patentees who exploit their patents only through licensing lost profits damages are not available and the reasonable royalty measure is the appropriate standard.
The reasonable royalty measure requires the court to determine what royalty the parties would have agreed to in a hypothetical licence negotiation conducted in good faith at the time the infringement commenced. The Georgia-Pacific factors a framework of fifteen considerations developed by US courts and widely cited in international patent damages jurisprudence have been referenced in Indian patent proceedings as a guide to the considerations relevant to the reasonable royalty assessment, though Indian courts have not formally adopted them as a binding framework. The relevant considerations include the commercial success of the patented invention, the royalties received by the patentee for comparable licences, the nature and scope of the licence that would have been agreed, the established royalty rates in the relevant industry and the relative bargaining positions of the parties.
In Monsanto Technology LLC v. Nuziveedu Seeds Ltd., the Delhi High Court engaged with the assessment of damages in the context of Monsanto’s patents over Bt cotton technology, examining the royalty structure for the licensed use of the technology and the appropriate compensation for unauthorised use. While the case involved complex issues of patentability and the terms of existing licence agreements, the court’s approach to damages assessment provided useful guidance on how Indian courts approach the quantification of patent infringement losses.
Enhanced Damages and Additional Remedies
Indian patent law does not expressly provide for punitive or exemplary damages in patent infringement cases Section 108’s reference to damages is generally understood to encompass only compensatory damages. However, the courts have awarded enhanced damages in cases of deliberate or flagrant infringement, treating the deliberateness of the infringement as a factor that justifies compensation at the higher end of the range of plausible assessments and have in some cases characterised such awards as including an element of additional damages to reflect the infringer’s conduct.
The Patents Act does not contain an express provision for additional damages comparable to Section 97 of the UK Patents Act or the enhanced damages provision of the US Patent Act. However, the courts’ general equitable jurisdiction and the provisions of the Code of Civil Procedure provide a basis for awarding costs and other consequences that effectively penalise deliberate infringement beyond the compensatory measure. The award of full costs including solicitor-client costs rather than merely party-and-party costs is a remedy that Indian courts have granted in cases of particularly egregious or deliberate infringement, effectively imposing a financial consequence on the infringer that goes beyond mere compensation for the patent holder’s loss.
Account of Profits – The Alternative Remedy
The account of profits is an alternative to damages the plaintiff must elect one or the other and having elected one cannot claim the other. The account of profits requires the infringer to disgorge the profits it has made from the infringing activities to pay to the patent holder the net profits attributable to the infringement. Unlike damages, which measure the patent holder’s loss, an account of profits measures the infringer’s gain and the two may produce significantly different results depending on the facts. Where the infringer has made substantial profits from the infringement more than the patent holder has lost the account of profits is the more valuable remedy. Where the patent holder’s loss exceeds the infringer’s gain as may occur where the patent holder had a higher-margin business that the infringement disrupted damages may be the more valuable election.
The assessment of an account of profits requires the court to identify the profits that are attributable to the infringement which in cases where the infringing product contains both patented and non-patented elements requires an apportionment of the infringer’s total profits between the patented and non-patented components. This apportionment exercise is among the most technically demanding in commercial litigation, requiring expert evidence on the contribution of the patented feature to the commercial value and profitability of the infringing product. In the context of complex technology products smartphones, for instance, which may incorporate hundreds of patented features the apportionment question is particularly acute and it has been at the centre of major patent disputes in multiple jurisdictions.
Delivery Up and Destruction
Section 108 of the Patents Act provides that the court may, in addition to an injunction and damages or an account of profits, order the delivery up or destruction of infringing goods, articles or documents in which the patent is embodied. The delivery up order requires the defendant to hand over the infringing goods to the plaintiff or to an officer of the court and the destruction order requires the infringing goods to be destroyed. These orders are typically sought in conjunction with a permanent injunction and are designed to ensure that the infringing goods cannot re-enter the market even if the defendant complies with the injunction prospectively.
The court’s discretion in granting delivery up and destruction orders is exercised in light of the proportionality of the relief the courts will not order the destruction of valuable goods where a less drastic remedy, such as modification to remove the infringing feature, is available and adequate. In pharmaceutical cases, the destruction of large quantities of infringing generic medicines raises public health concerns the destruction of drugs that patients need is not a consequence that courts impose lightly and in practice delivery up orders in pharmaceutical patent cases are relatively rare, with courts preferring to fashion injunctions that prevent further manufacture and sale without requiring the destruction of existing stocks.
Costs and Attorneys’ Fees
The general principle under Indian civil procedure is that costs follow the event the unsuccessful party bears the costs of the litigation. However, the courts have a broad discretion in the award of costs and may depart from this general principle where circumstances warrant. In patent litigation, the award of costs is an important ancillary remedy that can significantly affect the economics of the dispute a patent holder who wins the infringement claim but is awarded only nominal costs may find that the financial burden of the litigation substantially erodes the value of the damages awarded.
The courts have in some cases awarded solicitor-client costs the actual costs of the litigation rather than the lower taxed costs awarded under the standard scale in cases of particularly egregious infringement or particularly unreasonable conduct of the proceedings. The award of full costs is a significant deterrent to frivolous or vexatious patent enforcement and to deliberate infringement and it reflects the courts’ recognition that the costs of patent litigation are substantial and that the losing party should bear consequences proportionate to the nature of its conduct.
Anton Piller Orders and Mareva Injunctions
Beyond the core remedies of injunction, damages and account of profits, Indian courts have recognised the availability of more specialised procedural remedies that are particularly important in patent enforcement contexts. The Anton Piller order named after the English case of Anton Piller KG v. Manufacturing Processes Ltd. (1976) Ch 55 is an order that allows the plaintiff to enter the defendant’s premises without prior notice to search for and preserve evidence of infringement. It is a draconian remedy that is granted only in cases where there is strong evidence that the defendant possesses infringing goods or documents and that there is a real risk that they will be destroyed or concealed if notice is given. Indian courts have granted Anton Piller-type orders in patent infringement cases where the circumstances warranted, treating them as an exercise of the court’s inherent jurisdiction to preserve evidence and prevent the frustration of proceedings.
The Mareva injunction an order freezing the defendant’s assets to prevent dissipation before judgment is available in Indian courts as an exercise of the court’s jurisdiction to ensure that any judgment obtained by the plaintiff can be satisfied. In patent cases where the defendant is a foreign entity with limited assets in India or where there is evidence of asset dissipation, a Mareva injunction may be sought in conjunction with the substantive infringement claim to preserve the value of the anticipated award.
Conclusion
The remedies available for patent infringement in India the interlocutory and permanent injunction, damages or account of profits, delivery up and destruction and the ancillary remedies of costs and specialised procedural orders constitute a comprehensive and sophisticated framework for the enforcement of patent rights. Section 108 of the Patents Act is the statutory foundation, but the full architecture of patent remedies is built from the superimposition of equitable principles, procedural provisions and judicial decision-making that has given those statutory words their practical content.
The interlocutory injunction remains the most commercially significant of these remedies the relief that determines the competitive dynamics of the relevant market during the pendency of proceedings that may take years to resolve. The evolution of Indian courts’ approach to interim relief in patent cases from the relatively liberal grant of injunctions in the early years of modern Indian patent litigation to the more nuanced, public-interest-sensitive analysis exemplified by the Roche v. Cipla decision reflects a growing judicial sophistication in calibrating patent remedies to the specific circumstances of each case and to the broader public interest. For patent holders and defendants alike, understanding the standards and principles that govern the grant of each remedy and the strategic decisions that flow from those standards is among the most practically consequential bodies of knowledge in Indian intellectual property law.
References
- The Patents Act, 1970 https://ipindia.gov.in
- The Code of Civil Procedure, 1908 https://legislative.gov.in
- Wander Ltd. v. Antox India P. Ltd., (1990) Supp SCC 727 https://main.sci.gov.in
- Bajaj Auto Ltd. v. TVS Motor Company Ltd., (2009) 9 SCC 797 https://main.sci.gov.in
- F. Hoffmann-La Roche Ltd. v. Cipla Ltd., (2012) 49 PTC 356 (Del) https://delhihighcourt.nic.in
- Monsanto Technology LLC v. Nuziveedu Seeds Ltd., Delhi High Court https://delhihighcourt.nic.in
- Bayer Corporation v. Natco Pharma Ltd., IPAB, 2013 https://ipindia.gov.in
- Manual of Patent Office Practice and Procedure https://ipindia.gov.in
- TRIPS Agreement, WTO https://www.wto.org/english/docs_e/legal_e/27-trips.pdf
- National IPR Policy, 2016, DPIIT https://dpiit.gov.in
Compulsory Licensing Copyright Act Copyright Act 1957 Copyright Enforcement Copyright Infringement Copyright Law Copyright Rules Deceptive Similarity Descriptive Marks India Indian IP Framework Indian Patent Law Indian Trademark Law Intellectual Property Law IP Law India Patent Claims Patent Enforcement Patent Infringement Patent law Patent Revocation Patent Rule Patents Act 1970 Pharmaceutical Patents Section 3 Section 29 The Patent Act 1970 Trademark Infringement Trademark Registration Trade Marks Act 1999 Trade Marks Rules 2017 TRIPS Compliance